Human and mouse studies establish TBX6 in Mendelian CAKUT and as a potential driver of kidney defects associated with the 16p11.2 microdeletion syndrome

Nan Yang,Nan Wu,Shuangshuang Dong,Ling Zhang,Yanxue Zhao,Weisheng Chen,Renqian Du,Chengcheng Song,Xiaojun Ren,Jiaqi Liu,Davut Pehlivan,Zhenlei Liu,Jia Rao,Chunyan Wang,Sen Zhao,Amy M Breman,Huadan Xue,Hao Sun,Jianxiong Shen,Shuyang Zhang,Jennifer E Posey,Hong Xu,Li Jin,Jianguo Zhang,Pengfei Liu,Simone Sanna-Cherchi,Guixing Qiu,Zhihong Wu,James R Lupski,Feng Zhang,Amy M. Breman,Jennifer E. Posey,James R. Lupski
DOI: https://doi.org/10.1016/j.kint.2020.04.045
IF: 19.6
2020-10-01
Kidney International
Abstract:<p>Congenital anomalies of the kidney and urinary tract (CAKUT) are the most common cause of chronic kidney disease in children. Human 16p11.2 deletions have been associated with CAKUT, but the responsible molecular mechanism remains to be illuminated. To explore this, we investigated 102 carriers of 16p11.2 deletion from multi-center cohorts, among which we retrospectively ascertained kidney morphologic and functional data from 37 individuals (12 Chinese and 25 Caucasian/Hispanic). Significantly higher CAKUT rates were observed in 16p11.2 deletion carriers (about 25% in Chinese and 16% in Caucasian/Hispanic) than those found in the non-clinically ascertained general populations (about 1/1000 found at autopsy). Furthermore, we identified seven additional individuals with heterozygous loss-of-function variants in <em>TBX6</em>, a gene that maps to the 16p11.2 region. Four of these seven cases showed obvious CAKUT. To further investigate the role of <em>TBX6</em> in kidney development, we engineered mice with mutated <em>Tbx6</em> alleles. The <em>Tbx6</em> heterozygous null (i.e., loss-of-function) mutant (<em>Tbx6</em><sup><em>+/‒</em></sup>) resulted in 13% solitary kidneys. Remarkably, this incidence increased to 29% in a compound heterozygous model (<em>Tbx6</em><sup><em>mh/‒</em></sup>) that reduced <em>Tbx6</em> gene dosage to below haploinsufficiency, by combining the null allele with a novel mild hypomorphic allele (<em>mh</em>). Renal hypoplasia was also frequently observed in these <em>Tbx6</em>-mutated mouse models. Thus, our findings in patients and mice establish <em>TBX6</em> as a novel gene involved in CAKUT and its gene dosage insufficiency as a potential driver for kidney defects observed in the 16p11.2 microdeletion syndrome.</p>
urology & nephrology
What problem does this paper attempt to address?